Related Experiment Video

Updated: Aug 11, 2026

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Low doses of DNP-D-GL, a potent hapten-specific tolerogen, are immunogenic in vitro

D E Mosier

    Nature
    |September 11, 1975
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
    07:04

    Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

    Published on: September 16, 2018

    Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
    12:08

    Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

    Published on: May 17, 2019

    Related Experiment Videos

    Last Updated: Aug 11, 2026

    In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
    07:05

    In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

    Published on: November 28, 2017

    Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
    07:04

    Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

    Published on: September 16, 2018

    Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
    12:08

    Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

    Published on: May 17, 2019

    Related Concept Videos

    Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

    Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

    Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype.

    Journal of virology·2009

    Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.

    Journal of virology·2005

    HIV-1 envelope evolution and vaccine efficacy.

    Current drug targets. Infectious disorders·2005

    Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.

    Journal of virology·2001

    Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy.

    Journal of acquired immune deficiency syndromes (1999)·2000

    Virus and target cell evolution in human immunodeficiency virus type 1 infection.

    Immunologic research·2000

    T cells in systemic lupus erythematosus: biology and clinical value.

    Arthritis & rheumatology (Hoboken, N.J.)·2026

    P2X7R+CD8αβ+ T cells exacerbate postoperative ileus by inducing the loss of enterochromaffin cells.

    iScience·2026

    Incremental prognostic value of pan-immune-inflammation value in conservatively treated acute myocardial infarction: derivation and MIMIC-IV validation.

    Frontiers in cardiovascular medicine·2026

    Hierarchical prompting with reasoning large language models for immune checkpoint inhibitor-associated myocarditis evidence extraction pilot study.

    European heart journal. Digital health·2026

    Comparative Diagnostic Yield of Rapid Immunoassay-Based Tests and Nucleic Acid Testing for Transfusion-Transmissible Infections in a Tertiary Care Setting.

    Cureus·2026

    Atezolizumab-bevacizumab rechallenge after immune checkpoint inhibitor-associated myocarditis in advanced hepatocellular carcinoma: a case report.

    Frontiers in oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us